Key facts
- Verana Health’s last known valuation is $628.7M (Aug 2023).
- It has raised $366.5M; the latest was Later Stage VC in Mar 2025.
- Notable investors include GV, Bain Capital Ventures, Novo Holdings, Breyer Capital, Johnson & Johnson JJDC — 22 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 22 names
- ·Watchlist + deal alerts for Verana Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Verana Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Verana Health
Operator of a data insights platform intended to accelerate healthcare innovation and optimize drug and device development. The company's platform utilizes regulatory-grade data sets to uncover new market opportunities, enhance trial design and enrollment, gain competitive intelligence to benchmark commercial success, and target marketing efforts among others, enabling life science companies to make informed decisions using data from clinical specialty databases.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2008
- Employees
- 173
- Website
- veranahealth.com/
- Ownership
- Privately Held (backing)
Verana Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Verana Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Verana Health in its N-PORT filings yet. We sweep new filings monthly.